GH

Global Health Investment Corporation

North America, New York, United States, New York

Description

Global Health Investment Corporation ccelerates the development of technologies that improve human health around the world.

Investor Profile

Global Health Investment Corporation has made 10 investments, with 3 in the past 12 months and 30% as lead.

Stage Focus

  • Series D (30%)
  • Series Unknown (20%)
  • Series A (20%)
  • Series C (10%)
  • Series B (10%)
  • Seed (10%)

Country Focus

  • United States (90%)
  • Belgium (10%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Artificial Intelligence (Ai)
  • Life Science
  • Machine Learning
  • Biopharma
  • Wellness
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Global Health Investment Corporation frequently co-invest with?

The Engine
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
EV
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Norwest Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 2
AXA Investment Managers
Europe, Ile-de-France, France, Puteaux
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Aphelion Capital
North America, Colorado, United States, Littleton
Co-Investments: 1
AW
North America, Florida, United States, Miami
Co-Investments: 1
Mission BioCapital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Sands Capital Ventures
North America, Virginia, United States, Arlington
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 2

What are some of recent deals done by Global Health Investment Corporation?

Micron Biomedical

Atlanta, Georgia, United States

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.

BiopharmaBiotechnologyHealth CareWellness
Series AJan 16, 2025
Amount Raised: $16,000,000
CytoVale

South San Francisco, California, United States

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Artificial Intelligence (AI)Health DiagnosticsLife ScienceMachine Learning
Series DOct 10, 2024
Amount Raised: $100,000,000
Vaxess Technologies

Cambridge, Massachusetts, United States

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

BiotechnologyHealth CareMedical
Series UnknownMay 22, 2024
Amount Raised: $12,000,000
Biolinq

San Diego, California, United States

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

BiotechnologyHealth CareMedical DeviceWearables
Series DApr 4, 2024
Amount Raised: $58,000,000
CytoVale

San Francisco, California, United States

CytoVale is a medical technology company that focuses on advancing early detection technologies to diagnose immune-mediated diseases.

Artificial Intelligence (AI)Health DiagnosticsLife ScienceMachine Learning
Series CNov 15, 2023
Amount Raised: $84,000,000
Vaxess Technologies

Cambridge, Massachusetts, United States

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

BiotechnologyHealth CareMedical
Series UnknownSep 13, 2023
Amount Raised: $9,000,000
Micron Biomedical

Atlanta, Georgia, United States

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.

BiopharmaBiotechnologyHealth CareWellness
Series ANov 25, 2022
Amount Raised: $14,000,000
Centivax

South San Francisco, California, United States

Centivax is a healthcare-based agency that provides biotechnology, pharmaceutical, medical device manufacturing, and therapeutic services.

BiotechnologyHealth CareHealth DiagnosticsMedical
SeedNov 16, 2022
Amount Raised: $10,000,000
Vaxess Technologies

Cambridge, Massachusetts, United States

Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.

BiotechnologyHealth CareMedical
Series BNov 2, 2022
Amount Raised: $27,000,000
Univercells

Gosselies, Hainaut, Belgium

Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions

BiotechnologyHealth CareManufacturing
Series DOct 19, 2022
Amount Raised: $42,968,876